ESTRO 2025 - Abstract Book

S4283

RTT - Service evaluation, quality assurance and risk management

ESTRO 2025

Results: Of the 136 survey respondents, more males than females were actively undertaking a trial (27% Vs 22%) (p=0.67) and comparatively fewer females were willing to take part in such studies (75% Vs 89%) (p=0.058). Significantly more females reported refusing enrolment to or withdrawing from studies after being approached (37% Vs 0%) (p<0.001) (Figure 1) whilst within the domain of age, greater numbers of younger patients (35-60 yrs.) had also refused or withdrawn trial entry compared to older counterparts (60+ yrs.) (33% Vs 9%) (p=0.062) (Figure 2). Patients enrolled on CT’s tended to travel marginally further for their care compared to those who were not, 18.6 miles Vs 15.9 miles (p=0.18). The most commonly reported motivations behind trial enrolment were ‘altruism’ (64%) and ‘to give self best chance’ (64%), whilst ‘side effects’ (40.9%) and ‘safety worries’ (40.2%) were primary reasons for declining trial entry. When ranking preferences for trial information provision, ‘face to face consultation’ was the most favourable response (mean rank 2.3) whilst ‘digital approaches’ such as websites/apps and videos (mean rank 4.3) were the least preferential. Unfortunately, the sample consisted of so few participants from ethnic or religious diverse backgrounds that these metrics could not be analysed.